Transanal one-stage endorectal pull-through for Hirschsprung disease: experiences with 51 newborn patients.

INTRODUCTION

Transanal one-stage endorectal pull-through (TOSEPT) has been presented as the most recent progression in the treatment of Hirschsprung's disease (HD), which may be able to replace various previous techniques. This prospective study was designed to evaluate the efficacy and probable complications of this procedure in management of newborns with HD.

MATERIALS AND

METHODS

Fifty-one newborns (33 boys and 18 girls) underwent TOSEPT; all after being diagnosed by barium enema and rectal biopsy over a 52-month period. All patients were followed-up up from 6 to 48 months after hospital discharge.

RESULTS

There was no per-operative complication. Laparotomy was necessary in five children (9.8%). Average length of aganglionosis segment was 13.9 cm +/- 6.0 cm. Mean postoperative hospitalization time was 7.1 days. TOSEPT was redone in two patients (3.9%) because of aganglionosis segment remaining. After 6-48 months of follow-up, all children have been well now.

CONCLUSION

Our data suggested that TOSEPT is efficacious and safe in the management of newborn with HD.